arrow
W

William Audeh

medical affairs, agendia, inc , irvine, ca,
H指数:14
被引数:1,652

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial

疗效、安全性及预测性生物标志物:nab-paclitaxel联合pembrolizumab治疗激素受体阳性乳腺癌的随机试点试验

2025-11-280
OAAI
MammaPrint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world data

MammaPrint预测HR+HER2-早期乳腺癌的化疗获益:FLEX登记研究真实世界数据

2025-08-110
OAAI
Genomic profiling of primary tumor and lymph node metastasis in patients with clinically node-positive breast cancer: prospective cohort study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57–18, ABCSG-53, GBG 101)

临床淋巴结阳性乳腺癌患者原发肿瘤和淋巴结转移的基因组分析:TAXIS(OPBC-03、SAKK 23/16、IBCSG 57–18、ABCSG-53、GBG 101)框架下的前瞻性队列研究

2025-06-180
PRE
Distribution of MammaPrint, BluePrint, and Response Predictive Subtypes based on ImPrint and Reprint in ER+/HER2-Invasive Lobular Carcinoma - A FLEX sub study
2024-05-020
PRE
ImPrint immune signature in 10,000 early-stage breast cancer patients from the real-world FLEX database
2023-03-011
PRE